Intercure Ltd.
For the period ended Sep 8, 2026. Filed Sep 8, 2026.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
Sep 8, 2026 · Filed Sep 8, 2026
Use the contents to explore the available documents and sections.
Contents
INTERCURE LTD
(Translation of registrant’s name into English)
85 Medinat ha-Yehudim Street
Herzliya, 4676670, Israel
Tel: +972 77 460 5012
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
On September 8, 2026, InterCure Ltd. (the “Registrant”) issued a press release, titled “InterCure Regains Compliance with Nasdaq Minimum Bid Price Requirement”. A copy of the press release is furnished as Exhibit 99.1 to this Report of Foreign Private Issuer on Form 6-K.
| Exhibit No. | |
|---|---|
| 99.1 | Press Release issued by InterCure Ltd. on September 8, 2026, titled “InterCure Regains Compliance with Nasdaq Minimum Bid Price Requirement.” |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.